NCT06731556View on ClinicalTrials.gov

Analgesic Effects of Intranasal Diclofenac Sodium, Ibuprofen, and Paracetamol in Pediatric Tonsillectomy Cases

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

January 15, 2025

Conditions
Tonsil DiseasePain ManagementIntranasal Drug Administration
Interventions
DRUG

Intravenous paracetamol

Paracetamol was administered intravenously at a dose of 20 mg/kg/day, twice daily.

DRUG

Intranasal Paracetamol

Paracetamol at a concentration of 1.25 mg/mL was administered intranasally.

DRUG

Intranasal Diclofenac Sodium

Diclofenac sodium at a concentration of 0.0625 mg/mL was administered intranasally.

DRUG

Intranasal Ibuprofen

Ibuprofen at a concentration of 0.375 mg/mL was administered intranasally.

Trial Locations (1)

34093

Ramazan Bahadır KÜÇÜK, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT06731556 - Analgesic Effects of Intranasal Diclofenac Sodium, Ibuprofen, and Paracetamol in Pediatric Tonsillectomy Cases | Biotech Hunter | Biotech Hunter